Treatment strategy for HER2-positive breast cancer

ISSN： 1341-9625

Source： International Journal of Clinical Oncology, Vol.15, Iss.4, 2010-08, pp. : 335-340

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Proposed treatment guidelines for HER2-positive metastatic breast cancer in Europe

By Piccart M.J.

Annals of Oncology, Vol. 12, Iss. 12, 2001-12 ,pp. : 89-94

Springer Publishing Company

Access to resources Recommend Favorite

HER2-Positive Breast Cancer: Incidence, Prognosis, and Treatment Options

By Estévez L.G.

American Journal of Cancer, Vol. 2, Iss. 3, 2003-01 ,pp. : 169-179

Adis International

Access to resources Recommend Favorite

Trastuzumab emtansine in the treatment of HER-2-positive metastatic breast cancer patients

By Bighin Claudia Pronzato Paolo Del Mastro Lucia

Future Oncology, Vol. 9, Iss. 7, 2013-07 ,pp. : 955-957

Future Medicine

Access to resources Recommend Favorite

HER2-Positive Breast Cancer: Current Treatment Strategies

By Perez Edith Baweja Mansoina

Cancer Investigation, Vol. 26, Iss. 6, 2008-07 ,pp. : 545-552

Informa Healthcare

Access to resources Recommend Favorite

Dual human epidermal growth factor receptor 2 blockade for the treatment of HER2-positive breast cancer

By Alvarez Ricardo

Breast Cancer, Vol. 20, Iss. 2, 2013-04 ,pp. : 103-110

Springer Publishing Company

Access to resources Recommend Favorite